Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Common Equity (2016 - 2025)

HealthLynked (HLYK) has disclosed Common Equity for 10 consecutive years, with -$5.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity fell 181.1% to -$5.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$5.4 million, a 181.1% decrease, with the full-year FY2024 number at -$3.1 million, down 488.85% from a year prior.
  • Common Equity was -$5.4 million for Q3 2025 at HealthLynked, down from -$4.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $8.8 million in Q3 2021 to a low of -$5.4 million in Q3 2025.
  • A 5-year average of $1.6 million and a median of $1.6 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: skyrocketed 2392.9% in 2021, then tumbled 1967.95% in 2025.
  • HealthLynked's Common Equity stood at $7.2 million in 2021, then crashed by 95.63% to $314450.0 in 2022, then surged by 155.92% to $804730.0 in 2023, then plummeted by 488.85% to -$3.1 million in 2024, then tumbled by 73.64% to -$5.4 million in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Common Equity are -$5.4 million (Q3 2025), -$4.8 million (Q2 2025), and -$4.1 million (Q1 2025).